Literature DB >> 12662349

Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions.

Silvia López-Burillo1, Dun-Xian Tan, Juan C Mayo, Rosa M Sainz, Lucien C Manchester, Russel J Reiter.   

Abstract

DNA damage generated by oxygen-derived free radicals is related to mutagenesis, carcinogenesis and aging. In the last several years, hundreds of publications have confirmed that melatonin is a potent endogenous free radical scavenger. In the present in vitro study, we have examined the efficacy of three polyphenolic antioxidants, i.e. xanthurenic acid, resveratrol (3,4',5-trihydroxy-trans-stilbene) and (-)-epigallocatechin-3-gallate (EGCG) and two classical non-polyphenolic antioxidants, i.e. vitamin C (ascorbic acid) and alpha-lipoic acid (LA, 1,2-dithiolane-3-pentanoic acid) in inhibiting *OH-induced oxidative DNA damage. We compared the efficacy of these five antioxidants with the effectiveness of melatonin (N-acetyl-5-methoxytryptamine) and we also investigated the possible synergistic effects of melatonin with the other five molecules. Using high performance liquid chromatography (HPLC), the formation of 8-hydroxy-2-deoxyguanosine (8-OH-dG) in purified calf thymus DNA treated with the Fenton reagents, chromium(III) (as CrCl3) plus hydrogen peroxide (H2O2) (Cr(III)/H2O2), was measured in the presence or absence of the antioxidants alone or in combination with melatonin. 8-OH-dG is considered a biomarker of oxidative DNA damage. Among the antioxidants tested, melatonin was the most effective of these with an IC50 = 3.6 +/- 0.1 micro m. For the other antioxidants the IC50 values were as follows: xanthurenic acid (IC50 = 7.9 +/- 0.3), resveratrol (IC50 = 10.9 +/- 0.3), EGCG (IC50 = 5.7 +/- 0.3), vitamin C (IC50 = 16.9 +/- 0.5) and LA (IC50 = 38.8 +/- 0.7). These values differ from that of melatonin with a P < 0.01. Melatonin (1 micro M) reversed the pro-oxidant effect of resveratrol (0.5 micro M) and vitamin C (0.5 micro M), had an antagonistic effect when used in combination with EGCG (1 micro M) and it exhibited synergism in combination with vitamin C (0.5 micro M) and with LA (5 micro M).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12662349     DOI: 10.1034/j.1600-079x.2003.00041.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  30 in total

1.  Effect of melatonin on kidney cold ischemic preservation injury.

Authors:  Arif Aslaner; Omer Gunal; Hamdi Taner Turgut; Erdal Celik; Umran Yildirim; Rojbin Karakoyun Demirci; Umut Riza Gunduz; Hasan Calis; Sami Dogan
Journal:  Int J Clin Exp Med       Date:  2013-09-25

Review 2.  Melatonin and Parkinson's disease.

Authors:  Juan C Mayo; Rosa M Sainz; Dun-Xian Tan; Isaac Antolín; Carmen Rodríguez; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 3.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

4.  Ameliorative action of melatonin on oxidative damage induced by atrazine toxicity in rat erythrocytes.

Authors:  J S Bhatti; I P S Sidhu; G K Bhatti
Journal:  Mol Cell Biochem       Date:  2011-03-15       Impact factor: 3.396

5.  Antioxidant neuroprotection against ethanol-induced apoptosis in HN2-5 cells.

Authors:  Dhara S Sheth; Nuzhath F Tajuddin; Mary J Druse
Journal:  Brain Res       Date:  2009-06-16       Impact factor: 3.252

Review 6.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

7.  Resveratrol protects the ovary against chromium-toxicity by enhancing endogenous antioxidant enzymes and inhibiting metabolic clearance of estradiol.

Authors:  Sakhila K Banu; Jone A Stanley; Kirthiram K Sivakumar; Joe A Arosh; Robert C Burghardt
Journal:  Toxicol Appl Pharmacol       Date:  2016-04-27       Impact factor: 4.219

Review 8.  Melatonin: an established antioxidant worthy of use in clinical trials.

Authors:  Ahmet Korkmaz; Russel J Reiter; Turgut Topal; Lucien C Manchester; Sukru Oter; Dun-Xian Tan
Journal:  Mol Med       Date:  2008-11-04       Impact factor: 6.354

9.  Neurotoxins: free radical mechanisms and melatonin protection.

Authors:  Russel J Reiter; Lucien C Manchester; Dun-Xian Tan
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

Review 10.  Radioprotectors and mitigators of radiation-induced normal tissue injury.

Authors:  Deborah Citrin; Ana P Cotrim; Fuminori Hyodo; Bruce J Baum; Murali C Krishna; James B Mitchell
Journal:  Oncologist       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.